A temperature chart can look convincing while answering the wrong question. It may show that steam reached the main pipe, without demonstrating adequate exposure inside a valve cavity, filter assembly or remote branch. SIP qualification becomes defensible when the study identifies what must be treated, challenges the configurations that matter and explains how the recorded measurements support the intended sterilisation claim.
The practical task is to build an evidence chain from equipment design and cycle development to qualified performance and routine control. This article addresses installed steam-in-place systems. It separates equipment qualification from sterilisation validation, and temperature distribution from heat penetration and lethality. The examples are illustrative; numerical acceptance criteria must come from the approved application and supporting scientific rationale.
Start with the claim and its boundaries
Define whether the operation is intended to sterilise specified product-contact surfaces or provide a more limited steam sanitisation treatment. Describe the equipment boundary, connected assemblies, preconditions, operating configurations and protection after exposure. Include the surfaces of boundary valves and interfaces that can affect the next product. An unspecified statement such as “the vessel is sterile” leaves the treatment boundary and subsequent handling undefined.
SIP qualification demonstrates that the installed system and controls perform as intended within defined conditions. Sterilisation validation substantiates the process’s ability to deliver the intended microbiological outcome consistently. Their evidence overlaps, but the conclusions are different. A completed installation qualification cannot establish sterilisation efficacy, while a successful thermal study cannot resolve missing material certificates, uncontrolled software or an unqualified utility interface.
Prior cleaning is another distinct prerequisite. SIP does not replace cleaning validation, demonstrate acceptable detergent carryover or automatically control endotoxin. Define the permitted condition before starting: cleaning status, drainage, assembly, filters, calibration, utility availability and any hold time between cleaning and SIP. A thermal study performed on an ideal configuration is only useful if routine operations can reliably reproduce that configuration.
Current regulatory context
For EU human sterile medicinal manufacture, Annex 1 (2022) addresses sterilisation and SIP interfaces. Its SIP provisions connect routine monitoring with locations that heat most slowly and preservation of system integrity. Annex 15 (2015) remains the applicable qualification and validation annex at this editorial review. The 2026 Annex 15 concept paper is a proposal for revision, not a replacement requirement.
The FDA aseptic processing guidance, final in 2004, provides an official US reference for sterile manufacturing. Applicable regulations, marketing authorisation commitments and site procedures must also be considered. The study structure below is a GuideGxP recommendation. It does not prescribe a universal number of probes, successful runs, biological indicators, exposure minutes or a lethality target.
Three different measurements, three different questions
Temperature distribution describes spatial and temporal conditions within the defined system. It helps identify delayed heating, unstable exposure and differences between branches. It depends on the locations actually measured. A uniform set of traces from conveniently accessible points cannot demonstrate uniformity in an uninstrumented enclosed volume.
Heat penetration concerns transfer of heat to the location whose treatment matters, including relevant surfaces or internal features of an assembly. A probe surrounded by freely flowing steam may not represent a shielded interface or a location behind retained condensate. For SIP, the relevant challenge is often installed geometry and assembly condition rather than an autoclave-style product load. Describe exactly what “loaded” means if that term is used.
Lethality relates the time-temperature history to an appropriate microbial inactivation model. An equivalent-exposure calculation requires justified reference conditions, temperature sensitivity and assumptions about the organism and process. The calculation cannot establish steam contact, repair a misplaced probe or prove a sterile boundary remained intact afterwards. A reported F0 value without its model, input data and applicability is an incomplete result rather than a universal pass criterion.
| Evidence type | Question answered | Important limitation |
|---|---|---|
| Temperature distribution | Where and when do monitored locations reach required conditions? | Unmeasured geometry remains an uncertainty |
| Heat penetration | Does the relevant difficult location receive the intended exposure? | Probe placement can alter the local condition |
| Lethality assessment | What microbial effect does the justified thermal model predict? | The model depends on valid physical and microbiological assumptions |
| Biological indicator study, where justified | How does the selected challenge respond at its defined location? | The indicator and carrier may not represent every system condition |
| Boundary integrity evidence | Is the treated system protected until use? | An acceptable exposure does not prevent later contamination |
Use development to understand the system
Development work should investigate air displacement, condensate removal, heating behaviour, valve sequencing and utility demand before the formal qualification protocol is frozen. Record configuration and learning from unsuccessful trials. Repeatedly changing a recipe until a chart passes, without preserving the earlier results, removes information needed to explain the operating envelope.
Select relevant challenge conditions: the longest or most restrictive route, different filter assemblies, minimum available utility performance within specification, representative initial temperature and relevant simultaneous users. Consider wetness, retained liquid, component orientation and assembly tolerances where they can change heat transfer. Do not call one case “worst case” solely because it has the largest equipment volume.
The development output should explain why the selected operating range is suitable, which configurations it covers and where additional evidence is needed. It should also distinguish equipment problems from recipe problems. If a local drain is ineffective, the primary response may be redesign. Extending exposure may leave the underlying variability unresolved and introduce avoidable thermal stress on filters, seals or instruments.
Build a justified measurement plan
Begin with drawings, installed walkdowns and failure hypotheses. Candidate locations include branches with poor steam access, condensate drains, valve bodies, filter housings, large thermal masses and boundary interfaces. The final selection depends on geometry, prior data and risk. There is no generally valid probe quantity that can replace this rationale.
Document the exact location and attachment of each study sensor, its purpose, calibration status, response characteristics and relationship to routine instrumentation. Photographs or dimensioned sketches can prevent an apparently identical repeat study from measuring a different position. Assess whether a temporary sensor introduces a leak, changes drainage, bridges an air pocket or receives heat by conduction from a nearby metal surface.
Time alignment matters when comparing control-system data with an independent recorder. Define acquisition settings, time reference, measurement uncertainty and treatment of missing or invalid values before execution. Use calibration checks appropriate to the study and investigate significant drift. Do not average a problematic location together with better-performing locations to hide a local failure relevant to the sterilisation claim.
Protocol acceptance and repeatability
The approved protocol should specify prerequisites, configurations, measurement locations, sequence, parameter acceptance, data handling and deviation rules. Explain when exposure begins, which conditions must remain satisfied and what constitutes a failed or invalid study. If lethality is calculated, define the algorithm, units, relevant temperature range and handling of gaps. Preserve raw data alongside derived results.
Repeatability means that the intended performance can be reproduced under the approved conditions. Justify the study set using process knowledge, risk, variability and applicable regulatory expectations. Neither a single favourable run nor an unexplained standard number demonstrates why the evidence is sufficient. Define how configuration families are represented and what prevents an untested arrangement from being introduced under the same recipe.
Acceptance must address upper constraints as well as minimum treatment. Excessive exposure or differential pressure can damage components and compromise later performance. Review manufacturer limits for thermal cycling and installed assemblies. A cycle can meet a lower temperature requirement and still be unsuitable because it creates a new integrity risk during heating, cooling or repeated use.
Biological indicators: decide what they add
Where biological indicators are used, justify the selected organism, resistance characteristics, population, carrier, placement and recovery arrangements. Their purpose should be tied to a question the study needs to answer. The indicator’s condition and the local steam environment affect interpretation. Positive controls, handling and laboratory methods belong in the approved approach.
A satisfactory indicator result does not excuse invalid physical data or missing evidence for other locations. Conversely, an unexpected indicator result requires investigation of process delivery, indicator suitability, handling and testing rather than an immediate assumption that the equipment failed. Microbiology, engineering and quality should agree how physical and biological evidence will be interpreted together before the study starts.
Practical example: qualifying a changed filter assembly
An illustrative process transfers material through an assembly treated in place. A proposed filter housing has a different internal volume and drain arrangement, although its nominal connection size is unchanged. The existing recipe has a history of satisfactory operation. That history supports process knowledge but does not establish equivalence of the changed geometry.
The change assessment compares materials, orientation, venting, drainage, filter limits, steam access and the sterile boundary. Development studies show that the new housing’s lower region heats later than the former routine control point. The team investigates retained condensate and confirms the result with suitably positioned study sensors. It then modifies the installation within the approved design and tests the revised configuration.
Qualification establishes the relationship between the difficult location and routine instrumentation. The report defines the permitted filter configuration, recipe revision, maintenance conditions and any additional checks. Sterilisation validation conclusions address the microbiological objective separately. The assembly cannot be released solely because the PLC completed the unchanged cycle; release depends on closing the change’s documented evidence requirements.
Decision matrix for deviations and changes
| Observation or change | Immediate question | Evidence before acceptance |
|---|---|---|
| One study probe fails | Is this an instrument issue or missing critical process evidence? | Investigation, impact on study validity and justified disposition |
| Local heating is delayed | Is air, condensate, geometry or utility variation responsible? | Mechanism assessment and repeat study under relevant conditions |
| A routine sensor is relocated | Does it still represent the qualified difficult location? | Updated correlation and control-strategy assessment |
| A filter or valve type changes | Has steam access, thermal mass or boundary integrity changed? | Manufacturer review and targeted development or requalification |
| Data are missing during exposure | Can the required condition still be demonstrated? | Valid independent evidence or rejection of the unsupported conclusion |
Routine control must inherit the study’s learning
Identify which routine measurements demonstrate that the qualified process has been reproduced. Explain their relationship to the locations that heat most slowly and to relevant condensate drains. A study probe removed after qualification may have revealed the most important location; the report needs a defensible bridge from that observation to routine controls.
Define review of cycle records, alarms, excursions, maintenance and integrity checks. Trend heating time, differences between relevant sensors and changes in utility demand where they are meaningful. Set investigation rules around emerging behaviour as well as clear failures. A gradual change in a previously stable profile can indicate trap deterioration, altered assembly or instrument drift before a formal limit is exceeded.
Requalification planning should consider applicable regulatory minimum expectations, approved commitments, configuration risk, operating history and changes. Do not invent one interval for every SIP system. Reassess after changes that can affect steam distribution, drainage, control logic, sensor location, filter assembly or boundary integrity. The assessment should state which evidence remains valid and which must be regenerated.
Checklist before approving the conclusion
- The intended sterilisation claim, equipment boundary and permitted configurations are explicit and consistent with actual operations.
- Prerequisites, prior cleaning, assembly and utility conditions are traceable to the executed studies.
- Mapping locations have a documented rationale, and sensor placement and calibration evidence support the measurements.
- Distribution, penetration and lethality conclusions are separated, with model assumptions and limitations visible.
- All runs, including unsuccessful or invalid studies, remain traceable with approved investigations and dispositions.
- Routine monitoring is linked to the difficult locations identified, and the sterile boundary is protected through cooling and use.
- Changes, maintenance, component life and requalification responsibilities are reflected in controlled operating documents.
Key takeaways and references
The strongest SIP package explains why its measurements are relevant and how routine control preserves the qualified state. A collection of passing charts is insufficient if the configuration, exposure claim or post-cycle protection remains ambiguous. Use numerical criteria only when the site has justified their relevance. Keep open uncertainties visible until evidence or a design change resolves them.
The principal official references are EU GMP Annex 1, EU GMP Annex 15 and the FDA aseptic processing guidance. Their scope and legal role differ. For downstream interface decisions, see Aseptic Fill-Finish & Barrier Systems; coordinate utility assumptions through Pharma Engineering.
Related decisions
- SIP System Design in GMP Manufacturing: Steam Distribution, Air Removal and Condensate Control
- Qualification of CIP & SIP Systems: FAT, SAT, IQ, OQ and PQ
Explore all decisions in Cleaning, CIP & SIP Systems.
